Metallothionein: a new soldier in the fight against chronic renal hypoxia?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19148151.
- Also identified by DOI 10.1038/ki.2008.590.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sustained hypoxia appears to be an early and pivotal condition in the pathogenesis of chronic kidney disease, and may induce a number of adaptive/protective or harmful cellular responses. Kojima and colleagues found an upregulation of metallothioneins (MTs) among dozens of altered expression patterns. They demonstrated the astonishing properties of MTs within major intracellular signaling pathways beyond their notorious functions in heavy metal metabolism, detoxification, and ROS scavenging-HRE stimulation during normoxia and hypoxia together with ERK phosphorylation and mTOR activation.
Medical subject headings
- Cell Hypoxia
- Kidney Failure, Chronic
- Metallothionein
- Signal Transduction
- Up-Regulation